Mission
Basic science discoveries lead to drugs for treating human disease only after clinical trials define dosages/schedules/possible toxicities and show efficacy. Such clinical trials are expensive and are typically conducted by pharmaceutical companies who look for commercial potential in order to justify the costs involved. Therefore, potential therapies with scientific merit but uncertain financial return remain uninvestigated. GlobalCures Inc. (www.global-cures.org) was recently established as a non-profit medical research organization to fill this gap, with a focus on cancer therapies.
